Transcriptomics Technologies Market Players:
- Danaher Corporation
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Agilent Technologies, Inc.
- F. Hoffmann-La Roche AG
- Illumina, Inc.
- Thermo Fisher Scientific, Inc.
- Bio-Rad Laboratories, Inc.
- Pacific Bioscience of California, Inc.
- BioSkryb Genomics
- Agilent Technologies Inc.
- Parse Biosciences
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of transcriptomics technologies is estimated at USD 8.62 billion.
The global transcriptomics technologies market size was more than USD 8.01 billion in 2025 and is anticipated to witness a CAGR of more than 8.5%, crossing USD 18.11 billion revenue by 2035.
North America transcriptomics technologies market will hold more than 33% share by 2035, attributed to technological advancements and expanded drug discovery practices.
Key players in the market include Danaher Corporation, Agilent Technologies, Inc., F. Hoffmann-La Roche AG, Illumina, Inc., Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Pacific Bioscience of California, Inc., BioSkryb Genomics, Agilent Technologies Inc., Parse Biosciences.
